Transcatheter closure of large patent ductus arteriosus with severe pulmonary arterial hypertension in adults:immediate and two-year follow-up results

被引:0
|
作者
ZHANG Cao-jin [1 ]
HUANG Yi-gao [1 ]
HUANG Xin-sheng [1 ]
HUANG Tao [1 ]
HUANG Wen-hui [1 ]
XIA Chun-li [1 ]
MO Yu-jing [1 ]
机构
[1] Department of Cardiology,Guangdong General Hospital & Guangdong Cardiovascular Institute
关键词
D O I
暂无
中图分类号
R541.1 [先天性心脏血管病];
学科分类号
1002 ; 100201 ;
摘要
Background Transcatheter closure of patent ductus arteriosus(PDA) is a well established procedure and an accepted treatment modality for small to moderate-sized PDA.This study aimed to evaluate the immediate and follow-up results of transcatheter closure of large PDAs with severe pulmonary arterial hypertension(PAH) in adults. Methods After a complete hemodynamic evaluation differentiating from the reversibility of severe PAH,transcatheter closure of PDA was performed.Patients were followed up clinically and echocardiographically at 24 hours,1 month,3 months,6 months,12 months and 24 months after occlusion. Results Twenty-nine patients had successful occlusion,pulmonary artery pressure(PAP),left ventricular ejection fraction(LVEF) and fractional shortening(FS) significantly decreased immediately after occlusion((106±25) mmHg vs. (50±14) mmHg,P <0.01;(63.7±7.2)%vs.(51.4±10.1)%,P <0.01 and(36.9±8.2)%vs.(28.9+8.6)%,P <0.05, respectively).At 1 month after PDA closure,the signs and symptoms improved markedly in all 29 patients,and PDAs were completely closed and remained closed during the follow-up.Eighteen patients having different degrees of dyspnea were treated with angiotensin converting enzyme inhibitor(ACEI) and/or digoxin after occlusion.Nine patients whose pulmonary vascular resistence(PVR) >6 Wood units accepted targeted PAH therapy.After 1 to 3 months of peroral drug therapy,their exercise tolerance improved from New York Heart Association(NYHA) classⅢ-Ⅳto NYHA classⅠ.During follow-up,no latent arrhythmias were found,the left atrial diameter(LAD),left ventricular end-diastolic diameter(LVEDD), left ventricular end-systolic diameter(LVESD),left ventricular mass index(LVMI) and pulmonary artery systolic pressure (PASP) decreased significantly(P <0.05),and FS and LVEF recovered compared to the immediate postclosure state. However,FS and LVEF remained low compared to the preclosure state. Conclusions Transcatheter closure of large PDA with severe PAH is feasible,effective,and safe in adults.Significant left ventricular systolic changes may occur after closure of large PDA,and left ventricular function usually recovers within a few months.
引用
收藏
页码:3844 / 3850
相关论文
共 50 条
  • [31] Two-Year Follow-Up of Pulmonary Arterial Hypertension Patients Treated with Sildenafil
    Franchi, Sonia Meiken
    Barreto, Alessandra Costa
    Cicero, Cristina
    Pinheiro Castro, Claudia Regina
    de Sa Ribeiro, Zilma Vercosa
    Lopes, Antonio Augusto
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 94 (05) : 671 - 677
  • [32] Follow-Up Results of Device Occlusion of Patent Ductus Arteriosus
    Amoozgar, Hamid
    Salehi, Sara
    Farhadi, Pouya
    Edraki, Mohammad Reza
    Borzoee, Mohammad
    Ajami, Gholamhossein
    Cheriki, Sirous
    Mohammadi, Hamid
    IRANIAN JOURNAL OF PEDIATRICS, 2016, 26 (03)
  • [33] TRANSCATHETER OCCLUSION OF PATENT DUCTUS-ARTERIOSUS BY RASHKIND UMBRELLA DEVICE - FOLLOW-UP RESULTS
    ARORA, R
    KALRA, GS
    NIGAM, M
    KHALILLULAH, M
    AMERICAN HEART JOURNAL, 1994, 128 (03) : 539 - 541
  • [34] Treatment of Severe Pulmonary Hypertension in the Setting of the Large Patent Ductus Arteriosus
    Niu, Mary C.
    Mallory, George B.
    Justino, Henri
    Ruiz, Fadel E.
    Petit, Christopher J.
    PEDIATRICS, 2013, 131 (05) : E1643 - E1649
  • [35] Transvenous occlusion of patent ductus arteriosus with buttoned device in adults: Follow-up results
    SyamasundarRao, P
    Ho, KS
    Rey, C
    Onorato, E
    Sideris, EB
    CIRCULATION, 1997, 96 (08) : 1201 - 1201
  • [36] Safety and Outcomes of Transcatheter Closure of Patent Ductus Arteriosus in Children With Pulmonary Artery Hypertension
    Salavitabar, Arash
    Krishnan, Usha S.
    Turner, Mariel E.
    Vincent, Julie A.
    Torres, Alejandro J.
    Crystal, Matthew A.
    TEXAS HEART INSTITUTE JOURNAL, 2020, 47 (04) : 250 - 257
  • [37] Safety and Efficacy of Transcatheter Closure of Patent Ductus Arteriosus With Severe Mitral Regurgitation in Adults
    Wang, Zhongkai
    Chen, Tao
    Chen, Liang
    Qin, Yongwen
    Zhao, Xianxian
    JOURNAL OF INVASIVE CARDIOLOGY, 2016, 28 (01): : 30 - 33
  • [38] Transcatheter closure of patent ductus arteriosus using the Amplatzer duct occluder:: Initial results and mid-term follow-up
    Ruiz, AF
    Marín, JD
    Vidal, DR
    Gussoni, CC
    Granados, FM
    REVISTA ESPANOLA DE CARDIOLOGIA, 2002, 55 (10): : 1057 - 1062
  • [39] Post-interventional Evaluation and Follow-Up in Children With Patent Ductus Arteriosus Complicated With Moderate to Severe Pulmonary Arterial Hypertension: A Retrospective Study
    Rong, Xing
    Ye, Qiaofang
    Wang, Qiaoyu
    Wang, Jiajun
    Zhu, Qiongjun
    Chen, Youran
    Wu, Rongzhou
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [40] Patent ductus arteriosus stenting for palliation of severe pulmonary arterial hypertension in childhood
    D'Alto, Michele
    Santoro, Giuseppe
    Palladino, Maria T.
    Parisi, Francesco
    Russo, Maria G.
    CARDIOLOGY IN THE YOUNG, 2015, 25 (02) : 350 - 354